Alessio Piraino

8PUBLICATIONS
23CO-AUTHORS
Systems physiologyPharmacogenomicsPharmaceutical delivery technologiesMolecular medicinePacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 13, 2026
Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.

|Feb 05, 2025
Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis.

Fulvio Braido, Ioanna Vlachaki, Georgios F Nikolaidis

|Oct 31, 2023
BDP/FF NEXThaler to Improve Asthma Control Status in the Real World: The NEWTON Study.

Fulvio Braido, Enrico Arnaboldi, Sara Barile

|Oct 10, 2022
Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities.

Alfredo Chetta, Nicola Facciolongo, Cosimo Franco

|Aug 02, 2021
Narrative Analysis of the Impact of COVID-19 on Patients with Chronic Obstructive Pulmonary Disease, Their Caregivers, and Healthcare Professionals in Italy.

Eleonora Volpato, Stefano Centanni, Paolo Banfi

|Feb 04, 2021
The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol.

Luca Richeldi, Alessio Piraino, Francesco Macagno

Pageof 2

Frequent Collaborators

3 joint publications

Fulvio Braido

2 joint publications

Paola Rogliani

2 joint publications

Nicola Scichilone

1 joint publications

Veronica Chierici